Land surface temperature (LST) is a crucial parameter in climate and ecology, exerting significant influence on meteorological conditions, ecosystems, and human life. LST data sources are diverse, with remote sensing being the prevailing means of acquisition. FY-4A/AGRI offers high-quality LST products for East Asia. In this study, we evaluated the performance of the product in Hunan Province and conducted refined analysis of surface heat resources based on the 4km/1h resolution product over a two-year period. The results demonstrate that the FY-4A LST product effectively captures surface temperature (R=0.893), albeit with a relatively high error level (Bias=-6.295℃; RMSE=8.58℃), particularly in capturing high LST values. The performance of this product is superior in the eastern flat terrain area of Hunan Province compared to its performance in the western mountainous region due to environmental conditions causing systematic errors that contribute to instability in detection deviation for this product. Surface heat resources are more abundant in eastern Hunan Province than in mountainous areas located west and southwardly, and the detailed distribution of them at finer scales is mainly influenced by the terrain and climate conditions. There is no obvious seasonal difference in the distribution of heat resources except in winter, and rapid urbanization within Chang-Zhu-Tan urban agglomeration during two years has significantly altered the spatial distribution pattern of surface heat resources across Hunan Province. These findings provide a quantitative baseline for assessing FY-4A satellite's detection capability while serving as a reference for further application of its LST products and establishing foundations for divisional classification and utilization strategies pertaining to surface heat resources within Hunan Province.

Precise determination of the tectonothermal events at the Qinling-Qilian junction is extremely significant for understanding the tectonic evolution of the eastern branch of the Paleo-Tethys. The Banpo porphyry outcrops in the northern margin of the North Qinling were chosen as the research subject, and its formation and tectonic environment were analyzed using Zircon U-Pb age estimation and geochemical studies. The results indicated the final stage of the Triassic orogeny and the closure phase of the Paleo-Tethys. The weighted average values of 206Pb/238U ages of samples from 3 sites of the Banpo porphyry corresponded to 213.4 ±2.1 Ma (MSWD = 0.56), 213.0 ±1.6 Ma (MSWD = 0.92), and 213.2 ±4.4 Ma (MSWD = 1.6). This study revealed that the Banpo porphyry was formed during the Late Triassic (Norian). The porphyry with high SiO2 and high alkali is typical A-type granite, which belongs to the weak peraluminous shoshonite series. All the samples are rich in low rare earth elements. However, the heavy rare earth elements are low, especially Eu, which exhibits a seagull-type right-leaning partitioning curve. In addition, based on the regional geological data, it can be concluded that the Banpo porphyry was formed during the transition period from a post-orogenic environment to a non-orogenic environment. This study indicated the closure of the Paleo-Tethys-Mianxian-Lveyang Ocean by the Late Triassic as well as the completion of the collision between the North China and Yangtze Blocks along the Qinling orogenic belt.

Hyperuricemia (HC) was one of the important risk factors for gout, arteriosclerosis, and cardiovascular disease. Animal studies have shown that Lactobacillus plantarum can improve the microbiota, immune regulation, and inhibit the uric acid production. However, it was not clear whether L. plantarum can improve HC and intestinal microbiota. We used potassium oxonate (PO) to induce HC in male SD rats, and then treated L. plantarum TCI227 in a dose dependent (HC+LD, HC+MD, HC+HD) for 4 weeks, and examined weight organs, biochemical examination of blood and urine, and analyzed the intestinal microbiota in feces by 16s rDNA sequence analysis. In this study, TCI227 improved body weight, decreased creatinine, serum uric acid, and increased urine uric acid compared to the HC group. Furthermore, TCI227 increased short-chain fatty acids (SCFAs). In fecal microbiota (family), TCI227 increased the level of Lactobacillaceae, and then decreased the level of Deferribacteres and Prevotellaceae compared to the HC group. Finally, in fecal microbiota (genus), TCI227 decreased the level of Prevotella, and then increased the level of Lactobacillus and Ruminococcus compared to the HC group. This study suggested that TCI227 can improve HC and change the compositions of the intestinal microbiota in PO induced male HC SD rats.

This study evaluates the incidence and characteristics of adverse events (AEs) following the second COVID-19 booster dose, leveraging Taiwan's distinctive approach of extending booster vaccinations to all citizens, unlike the targeted high-risk group strategies in other countries. Utilizing data from Taipei Veterans General Hospital's Vaccine Adverse Event Reporting System (VAERS) from October 27, 2022, to January 19, 2023, the research examines AEs in 441 out of 1711 second booster recipients, considering factors like age, vaccine brands, and booster combinations. The findings reveal incidence rates (IR) of 25.6% (95% CI: 21.1-30.8) after the first booster and 24.9% (95% CI: 20.5-30.0) after the second, mostly non-serious, with those having AEs post-first booster 5 times more likely to report them again (Incidence rat rato, 5.02, P<0.001). Significantly, switching from the mRNA1273 vaccine to another brand reduced AE risk by 18%. The study underscores that AEs are more repetitive than cumulative with additional booster doses, advocating for personalized vaccination strategies based on individual medical histories and previous vaccine reactions. These insights are valuable for healthcare providers in discussing potential AEs with patients, thereby improving vaccine compliance and public trust, and for policymakers in planning future booster vaccination strategies.

While pioglitazone reduces insulin resistance and hepatic gluconeogenesis effectively in patients with T2DM, these benefits remained controversial in patients with ESRD. We compared MACCEs and mortality (overall, infection-related, and MACCE-related) of pioglitazone to that of DPP4-inhibitors in patients with T2DM and ESRD. From Taiwan’s national health insurance database, 647 pioglitazone users and 6080 DPP4-inhibitors users between April 1st, 2006 and December 31th, 2016 were followed from the 91th date after the ESRD certification till study outcomes, independently; withdraw from the NHI program, death, or Dec. 31th, 2017. After weighting, risks of MACCEs (10.48% vs 12.62% per person-years, [HR]: 0.85, 95% [CI]: 0.729–0.985) and all-cause mortality (12.86% vs 13.22% per person-years, [HR]: 0.88, 95% [CI]: 0.771–0.995) are significantly lower in pioglitazone group. Subgroup analysis found lower MACCEs risk in the pioglitazone users without insulin therapy (6.44% vs 10.04% [HR]: 0.59, 95% [CI]: 0.42–0.82) and lower MACCEs related death (2.76% vs 3.84% [HR]: 0.61, 95% [CI]: 0.40–0.95) in the pioglitazone group with dyslipidemia, when comparing with DPP4-inhibitors users. Pioglitazone is associated with lower all-cause mortality and MACCEs in diabetic patients with ESRD, compared to DPP4-inhibitors. These benefits were further significant in the non-insulin users and patients with dyslipidemia.

Antibacterial bone cements (ABCs), such as antibiotic-loaded bone cements (ALBCs), have been widely utilized in clinical treatments. Currently, bone cements loaded with vancomycin, gentamicin, tobramycin, or clindamycin are approved by the US Food and Drug Administration. However, traditional ALBCs exhibit drawbacks like burst release and bacterial resistance. Therefore, there is a demand for the development of antibacterial bone cements containing novel agents. In this review, we summarize the latest advancements in ABCs. More importantly, we provide an overview and outlook on novel antibacterial agent-loaded bone cements, including metallic antibacterial agents, pH-switchable antibacterial agents, cationic polymers, N-halamines, non-leaching acrylic monomers, antimicrobial peptides, etc. Offering novel perspectives for designing ABCs and treating bone infections.